Cargando…

The immunohistochemical evaluation of selected markers in the left atrium of dogs with end-stage dilated cardiomyopathy and myxomatous mitral valve disease – a preliminary study

BACKGROUND: Dilated cardiomyopathy (DCM) and myxomatous mitral valve disease (MMVD) are the most common diseases noted in dogs. Although their pathogenesis varies, both include a significant enlargement of the left atrium. The study was carried out on left atrial specimens obtained from 56 dogs, inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Janus, Izabela, Kandefer-Gola, Małgorzata, Ciaputa, Rafał, Noszczyk-Nowak, Agnieszka, Pasławska, Urszula, Tursi, Massimiliano, Nowak, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134068/
https://www.ncbi.nlm.nih.gov/pubmed/27980728
http://dx.doi.org/10.1186/s13620-016-0077-2
_version_ 1782471395377152000
author Janus, Izabela
Kandefer-Gola, Małgorzata
Ciaputa, Rafał
Noszczyk-Nowak, Agnieszka
Pasławska, Urszula
Tursi, Massimiliano
Nowak, Marcin
author_facet Janus, Izabela
Kandefer-Gola, Małgorzata
Ciaputa, Rafał
Noszczyk-Nowak, Agnieszka
Pasławska, Urszula
Tursi, Massimiliano
Nowak, Marcin
author_sort Janus, Izabela
collection PubMed
description BACKGROUND: Dilated cardiomyopathy (DCM) and myxomatous mitral valve disease (MMVD) are the most common diseases noted in dogs. Although their pathogenesis varies, both include a significant enlargement of the left atrium. The study was carried out on left atrial specimens obtained from 56 dogs, including those from 34 dogs with clinically diagnosed MMVD, 15 dogs with DCM and 7 dogs without heart disease (control group). Dogs in the MMVD and the DCM groups presented with left atrial enlargement and stage D heart failure. The specimens underwent immunohistochemical examination using desmin, vimentin, periostin and caspase-3 antibodies. RESULTS: There were alterations in the expression of the studied proteins in the study groups compared to the control group. The changes included: irregularity of desmin cross-striation and desmosomes, a higher amount of vimentin-positive cells, a change in the periostin expression pattern from cytoplasmic to extracellular, and a lower expression of caspase-3. The alterations were more pronounced in the DCM group than in the MMVD group. CONCLUSIONS: During heart failure, the pattern of desmin, vimentin, periostin and caspase-3 expression alters in the left atrium, regardless of the cause. The changes are more pronounced in dogs with DCM than in dogs with MMVD and similar left atrial enlargement, suggesting that volume overload may not be the only cause of myocardial changes in DCM.
format Online
Article
Text
id pubmed-5134068
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51340682016-12-15 The immunohistochemical evaluation of selected markers in the left atrium of dogs with end-stage dilated cardiomyopathy and myxomatous mitral valve disease – a preliminary study Janus, Izabela Kandefer-Gola, Małgorzata Ciaputa, Rafał Noszczyk-Nowak, Agnieszka Pasławska, Urszula Tursi, Massimiliano Nowak, Marcin Ir Vet J Research BACKGROUND: Dilated cardiomyopathy (DCM) and myxomatous mitral valve disease (MMVD) are the most common diseases noted in dogs. Although their pathogenesis varies, both include a significant enlargement of the left atrium. The study was carried out on left atrial specimens obtained from 56 dogs, including those from 34 dogs with clinically diagnosed MMVD, 15 dogs with DCM and 7 dogs without heart disease (control group). Dogs in the MMVD and the DCM groups presented with left atrial enlargement and stage D heart failure. The specimens underwent immunohistochemical examination using desmin, vimentin, periostin and caspase-3 antibodies. RESULTS: There were alterations in the expression of the studied proteins in the study groups compared to the control group. The changes included: irregularity of desmin cross-striation and desmosomes, a higher amount of vimentin-positive cells, a change in the periostin expression pattern from cytoplasmic to extracellular, and a lower expression of caspase-3. The alterations were more pronounced in the DCM group than in the MMVD group. CONCLUSIONS: During heart failure, the pattern of desmin, vimentin, periostin and caspase-3 expression alters in the left atrium, regardless of the cause. The changes are more pronounced in dogs with DCM than in dogs with MMVD and similar left atrial enlargement, suggesting that volume overload may not be the only cause of myocardial changes in DCM. BioMed Central 2016-12-01 /pmc/articles/PMC5134068/ /pubmed/27980728 http://dx.doi.org/10.1186/s13620-016-0077-2 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Janus, Izabela
Kandefer-Gola, Małgorzata
Ciaputa, Rafał
Noszczyk-Nowak, Agnieszka
Pasławska, Urszula
Tursi, Massimiliano
Nowak, Marcin
The immunohistochemical evaluation of selected markers in the left atrium of dogs with end-stage dilated cardiomyopathy and myxomatous mitral valve disease – a preliminary study
title The immunohistochemical evaluation of selected markers in the left atrium of dogs with end-stage dilated cardiomyopathy and myxomatous mitral valve disease – a preliminary study
title_full The immunohistochemical evaluation of selected markers in the left atrium of dogs with end-stage dilated cardiomyopathy and myxomatous mitral valve disease – a preliminary study
title_fullStr The immunohistochemical evaluation of selected markers in the left atrium of dogs with end-stage dilated cardiomyopathy and myxomatous mitral valve disease – a preliminary study
title_full_unstemmed The immunohistochemical evaluation of selected markers in the left atrium of dogs with end-stage dilated cardiomyopathy and myxomatous mitral valve disease – a preliminary study
title_short The immunohistochemical evaluation of selected markers in the left atrium of dogs with end-stage dilated cardiomyopathy and myxomatous mitral valve disease – a preliminary study
title_sort immunohistochemical evaluation of selected markers in the left atrium of dogs with end-stage dilated cardiomyopathy and myxomatous mitral valve disease – a preliminary study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134068/
https://www.ncbi.nlm.nih.gov/pubmed/27980728
http://dx.doi.org/10.1186/s13620-016-0077-2
work_keys_str_mv AT janusizabela theimmunohistochemicalevaluationofselectedmarkersintheleftatriumofdogswithendstagedilatedcardiomyopathyandmyxomatousmitralvalvediseaseapreliminarystudy
AT kandefergolamałgorzata theimmunohistochemicalevaluationofselectedmarkersintheleftatriumofdogswithendstagedilatedcardiomyopathyandmyxomatousmitralvalvediseaseapreliminarystudy
AT ciaputarafał theimmunohistochemicalevaluationofselectedmarkersintheleftatriumofdogswithendstagedilatedcardiomyopathyandmyxomatousmitralvalvediseaseapreliminarystudy
AT noszczyknowakagnieszka theimmunohistochemicalevaluationofselectedmarkersintheleftatriumofdogswithendstagedilatedcardiomyopathyandmyxomatousmitralvalvediseaseapreliminarystudy
AT pasławskaurszula theimmunohistochemicalevaluationofselectedmarkersintheleftatriumofdogswithendstagedilatedcardiomyopathyandmyxomatousmitralvalvediseaseapreliminarystudy
AT tursimassimiliano theimmunohistochemicalevaluationofselectedmarkersintheleftatriumofdogswithendstagedilatedcardiomyopathyandmyxomatousmitralvalvediseaseapreliminarystudy
AT nowakmarcin theimmunohistochemicalevaluationofselectedmarkersintheleftatriumofdogswithendstagedilatedcardiomyopathyandmyxomatousmitralvalvediseaseapreliminarystudy
AT janusizabela immunohistochemicalevaluationofselectedmarkersintheleftatriumofdogswithendstagedilatedcardiomyopathyandmyxomatousmitralvalvediseaseapreliminarystudy
AT kandefergolamałgorzata immunohistochemicalevaluationofselectedmarkersintheleftatriumofdogswithendstagedilatedcardiomyopathyandmyxomatousmitralvalvediseaseapreliminarystudy
AT ciaputarafał immunohistochemicalevaluationofselectedmarkersintheleftatriumofdogswithendstagedilatedcardiomyopathyandmyxomatousmitralvalvediseaseapreliminarystudy
AT noszczyknowakagnieszka immunohistochemicalevaluationofselectedmarkersintheleftatriumofdogswithendstagedilatedcardiomyopathyandmyxomatousmitralvalvediseaseapreliminarystudy
AT pasławskaurszula immunohistochemicalevaluationofselectedmarkersintheleftatriumofdogswithendstagedilatedcardiomyopathyandmyxomatousmitralvalvediseaseapreliminarystudy
AT tursimassimiliano immunohistochemicalevaluationofselectedmarkersintheleftatriumofdogswithendstagedilatedcardiomyopathyandmyxomatousmitralvalvediseaseapreliminarystudy
AT nowakmarcin immunohistochemicalevaluationofselectedmarkersintheleftatriumofdogswithendstagedilatedcardiomyopathyandmyxomatousmitralvalvediseaseapreliminarystudy